Pfizer (PFE) ended the recent trading session at $25.35, demonstrating a -1.17% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.14%.

Council of the Americas, with the support of Pfizer, convenes high-level roundtable discussions across Latin America.

This was the stock's second consecutive day of losses.

After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...

The attorney general is purging the Justice Department of employees connected to the Jan. 6 prosecutions, and the ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Most of America was blissfully unaware of the havoc wreaked by urban renewal until Kelo, when the veil was lifted. Anybody’s ...

Nurix Therapeutics shows strong BTK degrader data and key pharma ties, with risks but solid long-term potential. Find out why ...

In 2008, the largest automotive recall in history occurred when Takata Corp. air bags in several brands of cars were found to ...

Pfizer Inc. (NYSE: PFE) is one of the 13 Best Large Cap Stocks to Buy Right Now. On July 10, Pfizer Inc. (NYSE:PFE) shared ...

Each week on LinkedIn, business leaders announce moves to and from companies that play a role in our daily lives. See notable ...

A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...